Mark Howard Snyder is SVP, CHIEF LEGAL OFFICER of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 11,680 shares of HALO, which is worth approximately $548,492. The most recent transaction as insider was on Feb 16, 2024, when has been sold 2,577 shares (Common Stock) at a price of $36.1 per share, resulting in proceeds of $93,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.7K
0% 3M change
142.98% 12M change
Total Value Held $548,492

Mark Howard Snyder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
SELL
Payment of exercise price or tax liability
$93,029 $36.1 p/Share
2,577 Reduced 18.08%
11,680 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
-
4,796 Added 25.17%
14,257 Common Stock
Jan 03 2024
SELL
Payment of exercise price or tax liability
$105,801 $35.78 p/Share
2,957 Reduced 23.81%
9,461 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
-
7,611 Added 38.0%
12,418 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$154,584 $55.13 p/Share
2,804 Reduced 36.84%
4,807 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
7,611 Added 50.0%
7,611 Common Stock
MHS

Mark Howard Snyder

SVP, CHIEF LEGAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO